The addition of immunophenotyping, as done in this case, further helps to differentiate CTCL from pseudo-T-cell lymphomas and cutaneous pseudolymphomas, which often lack the characteristic CD4+ predominance and CD7 loss seen in MF [4,5]. The gene discussed is CD7; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.